Context
Marijuana smoke is very similar to tobacco smoke, but whether it has similarly adverse effects on pulmonary function is unclear.
Objective
To analyze associations between marijuana (both current and lifetime exposure) and pulmonary function
Design
We used repeated measurements of pulmonary function and smoking collected over 20 years in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Mixed linear modeling was used to account for individual age-based trajectories of pulmonary function and other covariates including tobacco use, which was analyzed in parallel as a positive control.
Setting
4 US cities, 1985–2006
Participants
Black and white men and women recruited at age 18–30 years and followed for 20 years
Main Outcome Measures
Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC)
Results
Marijuana exposure was nearly as common as tobacco exposure, but was mostly light (median 2–3 episodes per month). Tobacco exposure, both current and lifetime, was linearly associated with lower FEV1 and FVC. In contrast, the association between marijuana exposure and pulmonary function was non-linear (p<.001): at low levels of exposure, FEV1 increased by 13 ml/joint-year (95% confidence interval (CI): 6.4 – 20) and FVC by 20 ml/joint-year (95%CI:12 – 27); but at higher levels of exposure, these associations leveled off or even reversed. The slope for FEV1 was −2.2 ml/joint-year (95%CI:−4.6 – 0.3) at >10 joint-years, and −3.2 ml per marijuana smoking episode/month (95%CI:−5.8 – −0.6) at >20 episodes/month. The net association with FEV1 declined to or below baseline with very heavy use, but FVC remained significantly elevated in even heavy users (e.g., 76 ml [95%CI:34 – 117) at 20 joint-years).
Conclusions
Occasional and low cumulative marijuana use was not associated with adverse effects on pulmonary function.